Cushing e prêmio ABE&M 2006

EUNIS E-Learning Snapshots, 2006

The paper presents a preliminary analysis of the information obtained to date through the EUNIS ELearning Snapshots scheme. Members of EUNIS have contributed information on the way e-learning is organised in their universities and have given their views on elearning. The results of this survey present a picture of the deployment of e-learning in the universities represented in our sample; the u...

Harvey Cushing

Preventing Cushing: Iatrogenic Cushing Syndrome due to Ritonavir-Fluticasone Interaction

Ritonavir is commonly used in low doses to boost plasma levels of protease inhibitors in patients with human immunodeficiency virus (HIV) infections. It is also a potent inhibitor of cytochrome P450. We present a 50-year-old African American male with past medical history of HIV on highly active antiretroviral therapy (HAART), which also included ritonavir and long standing asthma that has been...

Cushing ' S Syndrome

In 1932 Harvey Cushing described a number of patients presenting a similar clinical picture which he had collected from the literature, and he added two more from his own records. The presence of minute adenomata of basophil cells in the anterior lobe of the pituitary gland was demonstrated at autopsy on some of them and Cushing regarded these as the causative lesions and called the syndrome 'p...

The Atypical Cushing Patient

Pituitary-induced bilateral adrenocortical hyperplasia also known as pituitary-dependent Cushing's disease (PDH) accounts for about 85% of all cases of spontaneous hypercortisolism in the dog. It results from either an adenohypophyseal ACTH-secreting microor macroadenoma or from excess pituitary ACTH secretion due to oversecretion of corticotrophin releasing factor (CRF) by the hypothalamus. Th...